Interventional Neuroradiology

The curriculum asks for knowledge of 'the principles of anaesthesia for neuroradiology'.

Resources


  • The scope of interventional neuroradiology is increasing; a broad range of indications exist for a variety of complex, lengthy procedures
  • Evidence for IR techniques is growing and anaesthetic input will be required for increasingly complex patients
  • Some patients will require straightforward neuroimaging, which does not require anaesthetic input
  • Equally, some procedures may be possible under LA only
  • Anaesthesia can:
    • Improve patient comfort
    • Improve image acquisition by ensuring patient immobility
    • Facilitate manipulation of physiology
    • Manage complications

Diagnostic

  • Patients may require elective, or emergency, CT or MRI imaging of the brain
  • The highest quality images are produced using digital subtraction angiography (DSA)
    • The neurovasculature is delineated using IV contrast
    • This image is then superimposed onto live, bone-subtracted fluoroscopy
    • This allows radiologists to review the progress of catheters through the vasculature

Therapeutic

Vascular Other
Endovascular coiling or embolization of intracerebral aneurysms Intra-arterial chemotherapy
Endovascular embolization of AVM or fistulae Mechanical thrombectomy
Pre-operative embolization of cerebral or spinal tumours Stereotactic surgery
Embolization for epistaxis Pain procedures e.g. trigeminal ganglion ablation
Investigation of idiopathic intracranial hypertension
± venous angioplasty or stenting
Sclerotherapy for venous angioma
Balloon angioplasty for carotid stenosis or vasospasm


  • Patients present across the spectrum of acuity:
    • Elective patients undergoing primary prevention techniques following e.g. incidental finding of an aneurysm, AVM or other intracranial pathology
    • Patients undergoing urgent neuroradiological procedures e.g. cerebral angiography and endovascular coiling of SAH
    • Emergency treatment of sudden neurological injury e.g. mechanical thrombectomy for thrombotic ischaemic stroke

Environmental/general considerations

  • Remote-site anaesthesia
  • Radiation safety
  • Poor lighting
  • Restricted access to patient, in particular the airway where the X-ray arm/scanner needs to move about
  • Monitoring should be AAGBI standard + temperature monitoring + urinary catheter (large volumes of flush, contrast and risk of DI)
  • Airway and vascular access should be securely fastened and have long circuits/extension lines
  • Risk of VTE

Anaesthetic and IR considerations

  • Neurosurgical-style anaesthetic to provide smooth, rapid wake-up
  • May require transfer of critically unwell patients to/from IR suites

  • Anticoagulation
    • Patients are anticoagulated with IV heparin
    • They undergo activated clotting time (ACT) monitoring to achieve a time of 270 - 390s i.e. 2 - 3x normal
    • This aims to reduce the risk of vessel thrombosis

    • Administration of other anticoagulant drugs may be required:
      • Aspirin
      • Abciximab (intra-arterial)
      • Clopidogrel
    • There is a risk of spontaneous bleeding and/or major haemorrhage

Perioperative management of the patient undergoing interventional neuroradiological procedures


History and examination

  • Neurological deficits prior to induction/intervention
  • Current GCS | pupillary responses
  • Symptoms of raised ICP
  • PMHx, DHx and allergies inc. risk factors for SAH e.g. hypertension, smoking
  • Previous neurosurgical procedures
  • Risk of contrast-induced nephropathy or contrast-associated reactions (or shellfish reaction)
  • Negative pregnancy test in female patients

Investigations

  • FBC | Clotting screen | G&S
    • Baseline haemoglobin is important in view of potential for peri-operative bleeding
    • Identify existing coagulopathy
    • May need to pre-order blood or other blood products

  • U&E | Glucose
    • Patients with head injuries or aneurysmal bleeds commonly have electrolyte disturbances
    • Particular attention to hyponatraemia, which may indicate SIADH or CSW
    • Hyperglycaemia potentiates the injurious effects of cerebral hypoperfusion

  • ECG; arrythmias and myocardial ischaemia are associated with SAH and TBI

  • Review of previous imaging; grade of SAH (Fisher score or WFNS Score) can allow fully informed discussion with patient/relatives

  • Anaesthetic goals include:
    • Haemodynamic stability and maintenance of CPP
    • Patient immobility
    • Rapid management of complications including haemorrhage
    • Smooth, rapid emergence to avoid undesirable effects on ICP/CVP
    • Analgesia

Monitoring and access

  • AAGBI
  • Wide-bore IV access is required in case of major haemorrhage
  • Arterial line
  • Urinary catheter due to long procedures, risk of DI and large volumes of contrast and flush used
  • Temperature monitoring and management as long procedures and negative sequelae of hypothermia

Induction

  • Haemodynamic stability is key:
    • Avoiding surges in blood pressure which will increase transmural pressure and risk rupture of unsecured aneurysms
    • Avoiding hypotension which will compromise CPP and risk cerebral hypoperfusion

  • Choices to obtund pressor response include:
    • Fentanyl (2 - 3μg/kg) or alfentanil
    • TCI remifentanil
    • Β-blockers e.g. labetalol 20 - 50mg IV, esmolol IV
    • IV lidocaine 1.5mg/kg
  • Otherwise induction agent and NMBA of choice may be used

  • Patients should be intubated e.g. reinforced ETT or S-F RAE
    • SAD are typically unsuitable for neuroradiology
    • Tube should be secured fastidiously, as there will be limited intra-procedural access

Maintenance

  • Both TIVA and volatile techniques are appropriate
    • Propofol/remifentanil TCI provides haemodynamic stability, leaves CBF and CMRO2 coupled and may preclude need for further paralysis
    • Sevoflurane will leave CBF and CMRO2 coupled below a MAC of 1.5

Analgesia

  • Angiography alone is only minimally stimulating
  • Dural interference and tumour embolization may be stimulating
    • Managed with opioids, either infused (remifentanil) or as boluses (fentanyl, alfentanil)
    • Avoid long-acting opioids which may cloud post-operative neurological assessment

Emergence

  • Aim for a smooth, rapid wake-up to:
    • Avoid rises in ICP associated with coughing or straining
    • Allow early neurological assessment

  • Patients may require HDU care for ongoing haemodynamic monitoring, neurological monitoring and/or BP management


CNS complications Non-CNS complications
Coil displacement / coil fracture Contrast anaphylaxis
Vasospasm Contrast nephropathy
CNS haemorrhage
- Perforated aneurysm (2 - 19%)
- Intracranial vessel injury or dissection
Non-CNS haemorrhage
- Puncture site
- Groin haematoma
- Retroperitoneal haematoma
Displacement of lines/tubes by moving XR arm

Haemorrhage

  • May be spontaneous, iatrogenic or related to surges in BP from inadequate anaesthesia
  • Management
    • Alert the radiologist
    • Depending on the stage of procedure and degree of bleeding, coiling may continue or transfer to theatre may be required for ventriculostomy or rescue craniotomy and clipping
    • Rapid BP reduction e.g. deepen anaesthesia, IV labetalol
    • Reversal of anticoagulation e.g. protamine 1mg per 100 units of initial heparin dose
    • Control of raised ICP if CNS haemorrhage; may require emergency craniotomy and clipping

Vessel occlusion

  • Thromboembolic events or misplacement/fracture of coils can occur
  • In thrombotic occlusion, management involves:
    • Direct lysis e.g. abciximab
    • Antiplatelet agents e.g. IV aspirin
    • BP manipulation to increase blood flow to ischaemic areas e.g. raise BP 30 - 40% above baseline

Vasospasm

  • Comprises of arterial constriction, seen angiographically, which causes clinical signs i.e. neurological deterioration
  • Thought to be mediated by the presence of extravasated blood in the subarachnoid space
  • Management involves:
    • Adequate systolic blood pressure (140 - 160mmHg in unsecured aneurysm, 160-180mmHg in secured aneurysms)
    • Euvolaemia
    • Prophylactic nimodipine for patients with a diagnosis of SAH for 21 days
      • 60mg enterally every 4hrs
      • 200 - 2,000μg/hr IV infusion (1 - 10ml/hr of a 200μg/ml solution)

Delayed cerebral ischaemia

  • A clinical syndrome occurring 4 - 12 days post-aneurysmal SAH
  • May take form of:
    • Symptomatic vasospasm
    • Delayed neurological deficit; typically focal neurological or cognitive deficits
    • Asymptomatic, delayed cerebral infarction
  • The only proven therapeutic intervention is nimodipine

  • Intra-operative MRI (iMRI) techniques are improving
    • Repeated scanning during surgery helps improve lesion resection or device manipulation
    • May improve clinical outcomes and provide economic benefit by avoiding repeated interventions

  • In stereotactic neurosurgery, various 'rings' are applied to the patient's skull and CT or MRI used to map the area of interest, which further restrict airway access